Submission strategy
US, EU, UK and global regulatory positions, interaction strategy and the sequencing of a submission path.
Senior regulatory judgement for health-authority interactions, submission strategy and fractional leadership — across FDA, EMA and MHRA pathways.
WHAT WE COVER
US, EU, UK and global regulatory positions, interaction strategy and the sequencing of a submission path.
Meeting strategy, question development, sponsor positions, briefing direction and rehearsal for pre-IND, Type B/C and scientific-advice meetings.
Senior ownership of a regulatory workstream without a full-time build.
Independent review for contradictions, missing dependencies and unsupported claims before filing.
WAYS TO ENGAGE
Build the position and team around an FDA, EMA or MHRA interaction.
Senior ownership of a regulatory or cross-functional workstream.
Submission and lifecycle documents produced to the same regulatory standard.
GO DEEPER
Application planning, SOP governance and the document-authoring backbone behind every CTD-format submission.
Explore Operations →Companion diagnostic co-development, precision-medicine regulatory strategy and global submission execution.
Explore Submissions →START WITH THE CONSTRAINT
Tell us the decision, deliverable or role you are working through. We will help identify the most useful next step.